Structure

Physi-Chem Properties

Molecular Weight:  358.21
Volume:  391.297
LogP:  5.435
LogD:  3.897
LogS:  -3.695
# Rotatable Bonds:  7
TPSA:  66.76
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.68
Synthetic Accessibility Score:  3.656
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.973
MDCK Permeability:  2.0234889234416187e-05
Pgp-inhibitor:  0.396
Pgp-substrate:  0.263
Human Intestinal Absorption (HIA):  0.072
20% Bioavailability (F20%):  0.069
30% Bioavailability (F30%):  0.015

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.096
Plasma Protein Binding (PPB):  99.49308013916016%
Volume Distribution (VD):  0.232
Pgp-substrate:  2.7827701568603516%

ADMET: Metabolism

CYP1A2-inhibitor:  0.131
CYP1A2-substrate:  0.246
CYP2C19-inhibitor:  0.049
CYP2C19-substrate:  0.099
CYP2C9-inhibitor:  0.377
CYP2C9-substrate:  0.422
CYP2D6-inhibitor:  0.062
CYP2D6-substrate:  0.127
CYP3A4-inhibitor:  0.044
CYP3A4-substrate:  0.092

ADMET: Excretion

Clearance (CL):  4.446
Half-life (T1/2):  0.624

ADMET: Toxicity

hERG Blockers:  0.052
Human Hepatotoxicity (H-HT):  0.949
Drug-inuced Liver Injury (DILI):  0.89
AMES Toxicity:  0.002
Rat Oral Acute Toxicity:  0.042
Maximum Recommended Daily Dose:  0.757
Skin Sensitization:  0.46
Carcinogencity:  0.041
Eye Corrosion:  0.003
Eye Irritation:  0.117
Respiratory Toxicity:  0.07

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC184053

Natural Product ID:  NPC184053
Common Name*:   Kuhistanol D
IUPAC Name:   (2R,3R)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-3-hydroxy-2-methyl-3,4-dihydrochromene-6-carboxylic acid
Synonyms:   kuhistanol D
Standard InCHIKey:  KSXMPLFGEDQAEG-BCVDLSEWSA-N
Standard InCHI:  InChI=1S/C22H30O4/c1-15(2)7-5-8-16(3)9-6-12-22(4)20(23)14-18-13-17(21(24)25)10-11-19(18)26-22/h7,9-11,13,20,23H,5-6,8,12,14H2,1-4H3,(H,24,25)/b16-9+/t20-,22-/m1/s1
SMILES:  C/C(=CCC[C@@]1(C)Oc2ccc(cc2C[C@H]1O)C(=O)O)/CCC=C(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL526664
PubChem CID:   10338460
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001549] Monoterpenoids
          • [CHEMONTID:0001564] Bicyclic monoterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24669 Ferula kuhistanica Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[10757719]
NPO24669 Ferula kuhistanica Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[12350156]
NPO24669 Ferula kuhistanica Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24669 Ferula kuhistanica Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified Inhibition = 70.3 % PMID[545630]
NPT2 Others Unspecified Inhibition = 77.3 % PMID[545630]
NPT2 Others Unspecified Inhibition = 61.8 % PMID[545630]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC184053 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9179 High Similarity NPC109778
0.9155 High Similarity NPC474044
0.9111 High Similarity NPC473777
0.911 High Similarity NPC256141
0.9044 High Similarity NPC302844
0.9037 High Similarity NPC327457
0.9037 High Similarity NPC86774
0.9034 High Similarity NPC88886
0.9034 High Similarity NPC104172
0.9 High Similarity NPC473988
0.8973 High Similarity NPC180351
0.8955 High Similarity NPC473993
0.8955 High Similarity NPC121104
0.8951 High Similarity NPC213900
0.8912 High Similarity NPC244577
0.8912 High Similarity NPC472420
0.8912 High Similarity NPC472422
0.8912 High Similarity NPC471676
0.8912 High Similarity NPC263384
0.8897 High Similarity NPC473133
0.8897 High Similarity NPC470670
0.8897 High Similarity NPC47388
0.8897 High Similarity NPC66991
0.8897 High Similarity NPC91902
0.8897 High Similarity NPC14875
0.8889 High Similarity NPC2401
0.8889 High Similarity NPC473744
0.8881 High Similarity NPC473090
0.8828 High Similarity NPC286038
0.8828 High Similarity NPC474302
0.8819 High Similarity NPC113397
0.8815 High Similarity NPC37512
0.8803 High Similarity NPC195357
0.8803 High Similarity NPC469911
0.8803 High Similarity NPC152771
0.8794 High Similarity NPC151946
0.8792 High Similarity NPC7989
0.8792 High Similarity NPC472583
0.8792 High Similarity NPC223701
0.8784 High Similarity NPC48671
0.8784 High Similarity NPC474772
0.8784 High Similarity NPC472423
0.8784 High Similarity NPC474744
0.8784 High Similarity NPC471677
0.8776 High Similarity NPC103116
0.8767 High Similarity NPC85773
0.8759 High Similarity NPC171656
0.8733 High Similarity NPC477958
0.8732 High Similarity NPC312881
0.8731 High Similarity NPC221798
0.8725 High Similarity NPC475790
0.8725 High Similarity NPC35567
0.8725 High Similarity NPC473996
0.8725 High Similarity NPC243171
0.8725 High Similarity NPC171651
0.8723 High Similarity NPC155963
0.8716 High Similarity NPC472421
0.8707 High Similarity NPC98809
0.8707 High Similarity NPC476394
0.8707 High Similarity NPC10097
0.8699 High Similarity NPC316769
0.8696 High Similarity NPC104854
0.869 High Similarity NPC18886
0.8675 High Similarity NPC471787
0.8671 High Similarity NPC80098
0.8671 High Similarity NPC287286
0.8667 High Similarity NPC165556
0.8667 High Similarity NPC469405
0.8667 High Similarity NPC293286
0.8662 High Similarity NPC279573
0.8662 High Similarity NPC211110
0.8658 High Similarity NPC472580
0.8658 High Similarity NPC472636
0.8658 High Similarity NPC262039
0.8658 High Similarity NPC278476
0.8658 High Similarity NPC319910
0.8658 High Similarity NPC474023
0.8658 High Similarity NPC474021
0.8658 High Similarity NPC254412
0.8658 High Similarity NPC262038
0.8652 High Similarity NPC294470
0.8652 High Similarity NPC38099
0.8652 High Similarity NPC26954
0.8649 High Similarity NPC89442
0.8649 High Similarity NPC139966
0.8649 High Similarity NPC307052
0.8649 High Similarity NPC472628
0.8643 High Similarity NPC311339
0.8639 High Similarity NPC202494
0.8639 High Similarity NPC472627
0.8639 High Similarity NPC472969
0.863 High Similarity NPC291153
0.863 High Similarity NPC124780
0.863 High Similarity NPC87486
0.863 High Similarity NPC294365
0.8623 High Similarity NPC282230
0.8623 High Similarity NPC183348
0.8613 High Similarity NPC2596
0.8609 High Similarity NPC108937
0.8609 High Similarity NPC217706
0.8609 High Similarity NPC470681
0.8609 High Similarity NPC259710
0.8609 High Similarity NPC304207
0.8609 High Similarity NPC477530
0.8609 High Similarity NPC207809
0.8609 High Similarity NPC48579
0.8609 High Similarity NPC279218
0.8603 High Similarity NPC475236
0.86 High Similarity NPC216035
0.86 High Similarity NPC56232
0.86 High Similarity NPC150123
0.86 High Similarity NPC10807
0.86 High Similarity NPC31627
0.86 High Similarity NPC477957
0.86 High Similarity NPC217149
0.86 High Similarity NPC285623
0.86 High Similarity NPC327269
0.86 High Similarity NPC138288
0.86 High Similarity NPC244583
0.86 High Similarity NPC161881
0.86 High Similarity NPC476238
0.8593 High Similarity NPC184219
0.8592 High Similarity NPC471069
0.8592 High Similarity NPC281014
0.8592 High Similarity NPC184861
0.8592 High Similarity NPC225106
0.8592 High Similarity NPC232246
0.8592 High Similarity NPC294456
0.8592 High Similarity NPC212124
0.8592 High Similarity NPC471068
0.8592 High Similarity NPC153818
0.8591 High Similarity NPC470908
0.8591 High Similarity NPC140133
0.8591 High Similarity NPC105136
0.8582 High Similarity NPC472525
0.8582 High Similarity NPC291189
0.8582 High Similarity NPC69403
0.8582 High Similarity NPC476018
0.8582 High Similarity NPC475029
0.8571 High Similarity NPC14822
0.8571 High Similarity NPC92589
0.8571 High Similarity NPC469700
0.8571 High Similarity NPC349525
0.8571 High Similarity NPC97812
0.8571 High Similarity NPC472629
0.8562 High Similarity NPC469683
0.8561 High Similarity NPC196979
0.8561 High Similarity NPC470977
0.8561 High Similarity NPC470976
0.8561 High Similarity NPC15083
0.8553 High Similarity NPC129053
0.8553 High Similarity NPC321372
0.8553 High Similarity NPC469936
0.8553 High Similarity NPC20530
0.8553 High Similarity NPC474738
0.8553 High Similarity NPC474609
0.8553 High Similarity NPC215917
0.8553 High Similarity NPC78554
0.8553 High Similarity NPC78492
0.8553 High Similarity NPC10754
0.8553 High Similarity NPC109967
0.8553 High Similarity NPC475797
0.8553 High Similarity NPC208152
0.8551 High Similarity NPC473019
0.8551 High Similarity NPC170546
0.8551 High Similarity NPC66246
0.8551 High Similarity NPC939
0.8543 High Similarity NPC248793
0.8543 High Similarity NPC180301
0.8542 High Similarity NPC64664
0.8542 High Similarity NPC79908
0.8533 High Similarity NPC70016
0.8533 High Similarity NPC215921
0.8533 High Similarity NPC209846
0.8533 High Similarity NPC328740
0.8533 High Similarity NPC471675
0.8533 High Similarity NPC477897
0.8533 High Similarity NPC289774
0.8531 High Similarity NPC471072
0.8531 High Similarity NPC471070
0.8531 High Similarity NPC471071
0.8523 High Similarity NPC473091
0.8523 High Similarity NPC164299
0.8521 High Similarity NPC78746
0.8521 High Similarity NPC475111
0.8521 High Similarity NPC188380
0.8521 High Similarity NPC224543
0.8514 High Similarity NPC51070
0.8514 High Similarity NPC222298
0.8514 High Similarity NPC285748
0.8511 High Similarity NPC224475
0.8511 High Similarity NPC34456
0.8511 High Similarity NPC50896
0.8511 High Similarity NPC213173
0.8511 High Similarity NPC62366
0.8511 High Similarity NPC180716
0.8511 High Similarity NPC326600
0.8511 High Similarity NPC204353
0.8506 High Similarity NPC239270
0.8506 High Similarity NPC303210

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC184053 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9007 High Similarity NPD4628 Phase 3
0.8803 High Similarity NPD7421 Clinical (unspecified phase)
0.8667 High Similarity NPD7096 Clinical (unspecified phase)
0.8618 High Similarity NPD7075 Discontinued
0.8477 Intermediate Similarity NPD6801 Discontinued
0.8467 Intermediate Similarity NPD4380 Phase 2
0.8312 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8311 Intermediate Similarity NPD6799 Approved
0.8301 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD7411 Suspended
0.8258 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD5844 Phase 1
0.8182 Intermediate Similarity NPD7819 Suspended
0.8138 Intermediate Similarity NPD2799 Discontinued
0.8133 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8117 Intermediate Similarity NPD1934 Approved
0.8105 Intermediate Similarity NPD6599 Discontinued
0.8099 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8099 Intermediate Similarity NPD6798 Discontinued
0.8095 Intermediate Similarity NPD1549 Phase 2
0.8082 Intermediate Similarity NPD2935 Discontinued
0.8074 Intermediate Similarity NPD9545 Approved
0.8056 Intermediate Similarity NPD6355 Discontinued
0.8027 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8027 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD7033 Discontinued
0.7973 Intermediate Similarity NPD2424 Discontinued
0.7972 Intermediate Similarity NPD2313 Discontinued
0.7959 Intermediate Similarity NPD2796 Approved
0.7949 Intermediate Similarity NPD8455 Phase 2
0.7931 Intermediate Similarity NPD5124 Phase 1
0.7931 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7922 Intermediate Similarity NPD7458 Discontinued
0.7908 Intermediate Similarity NPD5403 Approved
0.7905 Intermediate Similarity NPD6002 Phase 3
0.7905 Intermediate Similarity NPD6005 Phase 3
0.7905 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD6004 Phase 3
0.7905 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD3817 Phase 2
0.7895 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD6559 Discontinued
0.7867 Intermediate Similarity NPD3750 Approved
0.7848 Intermediate Similarity NPD7768 Phase 2
0.7843 Intermediate Similarity NPD5049 Phase 3
0.784 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD6166 Phase 2
0.784 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD3887 Approved
0.7815 Intermediate Similarity NPD2354 Approved
0.7806 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7806 Intermediate Similarity NPD3226 Approved
0.7793 Intermediate Similarity NPD6233 Phase 2
0.7792 Intermediate Similarity NPD920 Approved
0.7786 Intermediate Similarity NPD1608 Approved
0.7786 Intermediate Similarity NPD9717 Approved
0.7785 Intermediate Similarity NPD2346 Discontinued
0.7785 Intermediate Similarity NPD5402 Approved
0.7785 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD2533 Approved
0.7778 Intermediate Similarity NPD2532 Approved
0.7778 Intermediate Similarity NPD2534 Approved
0.7778 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD5401 Approved
0.777 Intermediate Similarity NPD4308 Phase 3
0.777 Intermediate Similarity NPD1510 Phase 2
0.7758 Intermediate Similarity NPD7074 Phase 3
0.7748 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD3818 Discontinued
0.774 Intermediate Similarity NPD1240 Approved
0.774 Intermediate Similarity NPD4060 Phase 1
0.7736 Intermediate Similarity NPD3882 Suspended
0.7733 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2801 Approved
0.7718 Intermediate Similarity NPD1551 Phase 2
0.7712 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD3823 Discontinued
0.7708 Intermediate Similarity NPD6832 Phase 2
0.7703 Intermediate Similarity NPD7097 Phase 1
0.7702 Intermediate Similarity NPD5494 Approved
0.7697 Intermediate Similarity NPD7054 Approved
0.7687 Intermediate Similarity NPD230 Phase 1
0.7687 Intermediate Similarity NPD447 Suspended
0.7682 Intermediate Similarity NPD1243 Approved
0.7682 Intermediate Similarity NPD1652 Phase 2
0.7671 Intermediate Similarity NPD4062 Phase 3
0.7662 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD3748 Approved
0.7651 Intermediate Similarity NPD7472 Approved
0.7647 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD1607 Approved
0.7632 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD7003 Approved
0.7622 Intermediate Similarity NPD2797 Approved
0.7622 Intermediate Similarity NPD1203 Approved
0.7619 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD6273 Approved
0.761 Intermediate Similarity NPD1465 Phase 2
0.7607 Intermediate Similarity NPD6232 Discontinued
0.7605 Intermediate Similarity NPD6797 Phase 2
0.7603 Intermediate Similarity NPD3764 Approved
0.7603 Intermediate Similarity NPD3268 Approved
0.76 Intermediate Similarity NPD4476 Approved
0.76 Intermediate Similarity NPD4477 Approved
0.7597 Intermediate Similarity NPD1511 Approved
0.7595 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7589 Intermediate Similarity NPD1091 Approved
0.7589 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD6190 Approved
0.7578 Intermediate Similarity NPD3749 Approved
0.7574 Intermediate Similarity NPD8313 Approved
0.7574 Intermediate Similarity NPD8312 Approved
0.7574 Intermediate Similarity NPD1241 Discontinued
0.7572 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD1778 Approved
0.7571 Intermediate Similarity NPD17 Approved
0.7566 Intermediate Similarity NPD2800 Approved
0.756 Intermediate Similarity NPD7251 Discontinued
0.7552 Intermediate Similarity NPD8651 Approved
0.755 Intermediate Similarity NPD2353 Approved
0.755 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD2344 Approved
0.7546 Intermediate Similarity NPD6959 Discontinued
0.7544 Intermediate Similarity NPD8434 Phase 2
0.7531 Intermediate Similarity NPD919 Approved
0.7518 Intermediate Similarity NPD3496 Discontinued
0.7517 Intermediate Similarity NPD9494 Approved
0.7515 Intermediate Similarity NPD7808 Phase 3
0.75 Intermediate Similarity NPD1512 Approved
0.75 Intermediate Similarity NPD5953 Discontinued
0.75 Intermediate Similarity NPD4307 Phase 2
0.7485 Intermediate Similarity NPD7286 Phase 2
0.747 Intermediate Similarity NPD7473 Discontinued
0.7465 Intermediate Similarity NPD422 Phase 1
0.7463 Intermediate Similarity NPD2684 Approved
0.7456 Intermediate Similarity NPD7685 Pre-registration
0.745 Intermediate Similarity NPD1933 Approved
0.745 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD1019 Discontinued
0.7448 Intermediate Similarity NPD5647 Approved
0.7447 Intermediate Similarity NPD4626 Approved
0.7439 Intermediate Similarity NPD8127 Discontinued
0.7434 Intermediate Similarity NPD5763 Approved
0.7434 Intermediate Similarity NPD5762 Approved
0.7431 Intermediate Similarity NPD3225 Approved
0.7429 Intermediate Similarity NPD1894 Discontinued
0.7425 Intermediate Similarity NPD7177 Discontinued
0.7419 Intermediate Similarity NPD7440 Discontinued
0.7415 Intermediate Similarity NPD7095 Approved
0.7413 Intermediate Similarity NPD3972 Approved
0.7413 Intermediate Similarity NPD1481 Phase 2
0.7405 Intermediate Similarity NPD1653 Approved
0.74 Intermediate Similarity NPD6653 Approved
0.7388 Intermediate Similarity NPD1358 Approved
0.7386 Intermediate Similarity NPD4534 Discontinued
0.7384 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD1613 Approved
0.7383 Intermediate Similarity NPD3140 Approved
0.7383 Intermediate Similarity NPD3142 Approved
0.7383 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7376 Intermediate Similarity NPD5691 Approved
0.7375 Intermediate Similarity NPD6385 Approved
0.7375 Intermediate Similarity NPD6386 Approved
0.7372 Intermediate Similarity NPD7843 Approved
0.7365 Intermediate Similarity NPD411 Approved
0.7365 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2309 Approved
0.7351 Intermediate Similarity NPD4538 Approved
0.7351 Intermediate Similarity NPD4536 Approved
0.7351 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7343 Intermediate Similarity NPD1535 Discovery
0.7342 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD3863 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD7157 Approved
0.7338 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7199 Phase 2
0.7333 Intermediate Similarity NPD4340 Discontinued
0.7329 Intermediate Similarity NPD2798 Approved
0.7329 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD4662 Approved
0.7325 Intermediate Similarity NPD4661 Approved
0.7322 Intermediate Similarity NPD7583 Approved
0.7321 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD3751 Discontinued
0.731 Intermediate Similarity NPD1283 Approved
0.7308 Intermediate Similarity NPD5058 Phase 3
0.7308 Intermediate Similarity NPD6666 Approved
0.7308 Intermediate Similarity NPD6667 Approved
0.7305 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD4110 Phase 3
0.7289 Intermediate Similarity NPD5710 Approved
0.7289 Intermediate Similarity NPD5711 Approved
0.7286 Intermediate Similarity NPD9493 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data